Health Care Up as Biotech Rebounds -- Health Care Roundup
Novavax ticked up, but remained deep in the red for the year to date. The Federal Trade Commission's lawsuit against three large pharmacy-benefit managers over insulin prices -- Cigna's Express ...
UnitedHealth Group: Will 2025 Finally Be A Normal Year?
UnitedHealth's 2025 guidance reflects optimism with expected revenue growth of 13% and EPS growth of 7%, aiming for a "normal ...
FOX 13 Tampa Bay11d
Doctors urge getting checked as colon cancer rises in the U.S.
March is Colorectal Cancer Awareness Month, and Florida doctors are taking this opportunity to share their concerns and ...
Fierce Healthcare14d
Optum Rx to reduce reauthorizations on 80 drugs
Optum Rx announced Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs. The pharmacy benefit management arm of UnitedHealth Group said it will work with ...
Seeking Alpha14d
UnitedHealth says Optum Rx to cut up to 25% of drug reauthorizations
UnitedHealth Group (NYSE:UNH) announced Wednesday its pharmacy benefit manager, Optum Rx, would eliminate up to 25% of reauthorizations, easing patients’ access to multiple medications when ...
Nasdaq27d
2 Dow Stocks to Buy Hand Over Fist in March and 1 to Avoid
in any economic climate. But the more impressive growth story attached to UnitedHealth Group is its healthcare solutions subsidiary Optum. Optum provides a host of services, including primary care ...
BioPharma Dive28d
Vertex’s new pain drug gets first coverage nod from major insurer
Optum Rx, a pharmacy benefit manager owned by one of the country’s largest insurance companies, UnitedHealth Group, has added a new, much-anticipated pain drug to some of its commercial formularies.